About In-vitro diagnostics (IVD)
IVD procedures are conducted outside of a living organism in a test tube, petri dish, or culture dish. Whereas, in vivo diagnostics are carried out inside a living organism. IVD products are intended to collect biological samples such as blood, sputum, urine, spinal fluid, and DNA from a patient's body. They are analyzed in hospitals, clinics, and laboratories. IVD products are reagents and instruments that help in the diagnosis of diseases.
MIR's analysts forecast the in-vitro diagnostics (IVD) market in China to grow at a CAGR of 14.39% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of in-vitro diagnostics (IVD) market in China for 2017-2021. To calculate the market size, the report considers the new installations/shipments/sales/volume/value.
MIR's report, In-vitro diagnostics (IVD) Market in China 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Other prominent vendors
Atlas Link Biotech
Changchun Wancheng Bio-elect
Changsha City Epower Electronics & Science
Chongqing Haray International Business
Maya Medical Equipment Limited
Jiangxi Zhongchenda Industrial Investment
Jiaxing Smir Medical Devices
Johnson & Johnson
Nantong Egens Biotechnology
Nantong Voyage International Trade
Shanghai Jiuyi International Trade
Shanghai Kehua Bio-Engineering
Shanghai Outdo Biotech
Shenzhen Fitconn Technology
Shiny Health Import & Export
Shenzhen New Industries Biomedical Engineering
Wuhan HNC Technology
Yuan Yu Bio-Tech
Zhejiang Orient Gene Biotech
Increase in incidences of chronic and infectious diseases
For a full, detailed list, view our report
Increase in demand and expectations of improved healthcare facilities
For a full, detailed list, view our report
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
MIR Announces the Publication of its Research Report In-vitro diagnostics (IVD) Market in China 2017-2021
MIR recognizes the following companies as the key players in the in-vitro diagnostics (IVD) market in China: Roche Diagnostics, Abbott, and Siemens Healthineers.
Other Prominent Vendors in the market are: Atlas Link Biotech, Autobio Diagnostics, Bioneovan, Bioptik Technology, Bio-Rad Laboratories, Boson Biotech, C&G Biotech, Cepheid, Changchun Wancheng Bio-elect, Changsha City Epower Electronics & Science, Chongqing Haray International Business, Cusabio Biotech, Dako, Fudakang Ind'l, GE Healthcare, Grifols, Maya Medical Equipment Limited, Hologic, Illumina, Innovation Biotech, Intec Products, Jiangxi Zhongchenda Industrial Investment, Jiaxing Smir Medical Devices, Johnson & Johnson, Luminex, Nantong Egens Biotechnology, Nantong Voyage International Trade, PerkinElmer, Qiagen, Quest Diagnostics, Quicking Biotech, Secure Detect, Shanghai Jiuyi International Trade, Shanghai Kehua Bio-Engineering, Shanghai Outdo Biotech, Shenzhen Fitconn Technology, Shiny Health Import & Export, Shenzhen New Industries Biomedical Engineering, Sunrising Enterprise, Wuhan HNC Technology, Yuan Yu Bio-Tech, and Zhejiang Orient Gene Biotech.
Commenting on the report, an analyst from MIR's team said: The latest trend gaining momentum in the market is companion diagnostics. Companion diagnostics or simply CDx are the tests done to ensure safe and effective use of a corresponding drug or a biological product. It helps a healthcare professional to measure a therapeutic product's applicability on a specific individual. These tests are developed along with the manufacturing of the related drugs. Its application detects whether an individual is a right candidate for the particular therapy or not. These tests can be mainly seen in the oncology field where drugs are too expensive.
According to the report, one of the major drivers for this market is increase in incidences of chronic and infectious diseases. There is a steep rise in incidences of chronic and infectious diseases that have become a major concern for the Chinese government as well as a major driver for the growth of the IVD market in China. The demand for various diagnostic tests such as glucose monitoring, cardiac biomarkers, and cholesterol testing is increasing due to the growing prevalence of diabetes and obesity.
Further, the report states that one of the major factors hindering the growth of this market is increase in demand and expectations of improved healthcare facilities. Over the past decade, the demand for IVD tests has increased, as more number of individuals are opting for diagnostics tests. The increased health consciousness and rise in middle-class population with more spending power have increased the demand for best-quality care. With the rise in urbanization, people are expecting wider and quicker access to the diagnostic tests to avail right treatment at the right time. However, the rising burden of the population makes it more tough for the Chinese government, as there are inadequate healthcare facilities to meet the growing diagnostics demand of China.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit- https://www.MIR.com/report/ivd-market-in-china
MIR, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our market research, please visit- https://www.MIR.com/industries/vitro-diagnostics
Table of Contents
PART 01:Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
Β Market outline
PART 05: Market landscape
Β Market overview
Β Market size and forecast
Β Five forces analysis
PART 06: Healthcare structure in China
Β Healthcare expenditure in China
Β Healthcare reforms
Β IVD product registration in China
PART 07: Market segmentation by application
Β IVD market segmentation
Β Market segmentation by application during the forecast period
Β Molecular diagnostics
Β Clinical microbiology
Β POC testing
Β Tissue diagnostics
PART 08: Market segmentation by end-user
Β Market overview
Β Research institutes
Β Independent laboratories
PART 09: Decision framework
PART 10: Drivers and challenges
Β Market drivers
Β Market challenges
PART 11: Market trends
Β Healthcare infrastructure expansion
Β Companion diagnostics
Β Continuous advances in IVD procedures
PART 12: Vendor landscape
Β Competitive landscape
Β Other prominent vendors
PART 13: Key vendor analysis
Β Roche Diagnostics
Β Siemens Healthineers
Β Key companies to watch
PART 14: Appendix
Β List of abbreviations
List of Exhibits
Exhibit 01: Involvement of diagnostics across the healthcare value chain of a person
Exhibit 02: Market analysis of IVD share in top five medical device segments
Exhibit 03: Types of IVD in China
Exhibit 04: IVD market in China 2016-2021 ($ millions)
Exhibit 05: Five forces analysis
Exhibit 06: Healthcare expenditure per capita 2014 ($ millions)
Exhibit 07: Changes in healthcare reforms in China post 2009
Exhibit 08: Overview of IVD product registration in China
Exhibit 09: Segmentation of IVD market by application in 2016 (%)
Exhibit 10: Segmentation of IVD market by application in 2021 (%)
Exhibit 11: IVD market segmentation by application 2016-2021 ($ millions)
Exhibit 12: Immunochemistry market in China 2016-2021 ($ millions)
Exhibit 13: Market overview of immunochemistry in China 2016
Exhibit 14: SMBG market in China 2016-2021 ($ millions)
Exhibit 15: Market overview of SMBG in China 2016
Exhibit 16: Molecular diagnostics market in China 2016-2021 ($ millions)
Exhibit 17: Market overview of molecular diagnostics in China 2016
Exhibit 18: Clinical microbiology market in China 2016-2021 ($ millions)
Exhibit 19: Market overview of clinical microbiology in China 2016
Exhibit 20: POC testing market in China 2016-2021 ($ millions)
Exhibit 21: Market overview of POC testing in China 2016
Exhibit 22: Tissue diagnostics market in China 2016-2021 ($ millions)
Exhibit 23: Market overview of tissue diagnostics in China 2016
Exhibit 24: Hematology market in China 2016-2021 ($ millions)
Exhibit 25: Market overview of hematology in China 2016
Exhibit 26: Hemostasis market in China 2016-2021 ($ millions)
Exhibit 27: Market overview of hemostasis in China 2016
Exhibit 28: Hospitals in China
Exhibit 29: Segmentation of IVD market in China by end-users in 2016 (%)
Exhibit 30: Segmentation of IVD market in China by end-users in 2021 (%)
Exhibit 31: Market overview of end-user segment of IVD market in China 2016
Exhibit 32: Competitive structure analysis of IVD market in China
Exhibit 33: Market position of key vendors in China
Exhibit 34: Roche Diagnostics IVD division sales in 2016
Exhibit 35: Roche Diagnostics: Strength assessment
Exhibit 36: Roche Diagnostics: Strategy assessment
Exhibit 37: Roche Diagnostics: Opportunity assessment
Exhibit 38: Abbott: Strength assessment
Exhibit 39: Abbott: Strategy assessment
Exhibit 40: Abbott: Opportunity assessment
Exhibit 41: Siemens Healthineers: Strength assessment
Exhibit 42: Siemens Healthineers: Strategy assessment
Exhibit 43: Siemens Healthineers: Opportunity assessment
Companies Mentioned are - Roche Diagnostics, Abbott, Siemens Healthineers, Atlas Link Biotech, Autobio Diagnostics, Bioneovan, Bioptik Technology, Bio-Rad Laboratories, Boson Biotech, C&G Biotech, Cepheid, Changchun Wancheng Bio-elect, Changsha City Epower Electronics & Science, Chongqing Haray International Business, Cusabio Biotech, Dako, Fudakang Ind'l, GE Healthcare, Grifols, Maya Medical Equipment Limited, Hologic, Illumina, Innovation Biotech, Intec Products, Jiangxi Zhongchenda Industrial Investment, Jiaxing Smir Medical Devices, Johnson & Johnson, Luminex, Nantong Egens Biotechnology, Nantong Voyage International Trade, PerkinElmer, Qiagen, Quest Diagnostics, Quicking Biotech, Secure Detect, Shanghai Jiuyi International Trade, Shanghai Kehua Bio-Engineering, Shanghai Outdo Biotech, Shenzhen Fitconn Technology, Shiny Health Import & Export, Shenzhen New Industries Biomedical Engineering, Sunrising Enterprise, Wuhan HNC Technology, Yuan Yu Bio-Tech, and Zhejiang Orient Gene Biotech.
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.